Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors-Reference-Cited by-同舟云学术

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors

Published:2018-10-16 Issue:81 Volume:9 Page:35251-35265
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ottaiano Alessandro¹,Scotti Valerio²,De Divitiis Chiara³,Capozzi Monica³,Romano Carmen³,Cassata Antonino³,Casaretti Rossana³,Silvestro Lucrezia³,Nappi Anna³,Vicario Valeria³,De Stefano Alfonso³,Tafuto Salvatore³,Berretta Massimiliano⁴,Nasti Guglielmo¹,Avallone Antonio³

Affiliation:

1. Department of Abdominal Oncology, SSD-Innovative Therapies for Abdominal Metastases, Istituto Nazionale Tumori di Napoli G. Pascale IRCCS, National Cancer Institute, 80131, Naples, Italy

2. San Rossore Clinic, Viale delle Cascine, 56122, Pisa, Italy

3. Department of Abdominal Oncology, Experimental Clinical Oncology, Istituto Nazionale Tumori di Napoli G. Pascale IRCCS, National Cancer Institute, 80131, Naples, Italy

4. Department of Medical Oncology, CRO Aviano, National Cancer Institute, 33081, Aviano, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Treatment Strategy for Oligometastases/Oligo-Recurrence of Colorectal Cancer;Cancers;2023-12-27

2. Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study;BMC Cancer;2023-10-19

3. Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives;Cancers;2023-03-17

4. Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review;Cancers;2022-07-03

5. Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer;Cancer Management and Research;2021-09